Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Poster Exhibition<br />
P6.12 <strong>Cell</strong> Separation System for Fully Automated Cl<strong>in</strong>ical Scale<br />
Separation of CD133+ <strong>Cell</strong>s from Bone Marrow Aspirates<br />
Mike Essl, Bergisch Gladbach<br />
P6.13 Automated cl<strong>in</strong>ical scale PBMC generation <strong>and</strong> NK cell expansion<br />
Markus Granz<strong>in</strong>, Bergisch Gladbach<br />
P6.14 Semi-automated Production of Platelet Lysate<br />
Kar<strong>in</strong> Plöderl, L<strong>in</strong>z<br />
P6.15 Study<strong>in</strong>g jo<strong>in</strong>t regeneration <strong>in</strong> the red-spotted newt notophthalmus<br />
viridescens<br />
Christiane Knopp, Bad Nauheim<br />
P6.16 Evaluation of the <strong>in</strong>fluence of two different hydroxyethyl starch<br />
solutions (6 % HES 450 0.7 <strong>and</strong> 6 % HES 200 0.59) <strong>in</strong> the process<strong>in</strong>g<br />
of Cord Blood<br />
Susanne Suessner, L<strong>in</strong>z<br />
P6.17 Evaluation of the effectiveness of several antimicrobial treatments<br />
<strong>in</strong> tissue bank<strong>in</strong>g<br />
Susanne Suessner, L<strong>in</strong>z<br />
P6.18 Mult<strong>in</strong>ucleated Amniotic <strong>Cell</strong>s by <strong>Cell</strong> Fusion<br />
Lorna Devkota, Wake Forest<br />
P7<br />
<strong>Cell</strong>ular Immune Modulation<br />
P7.01 HSP70 peptide complexes: potent mediators for the generation of<br />
antiviral T cells particularly with regard to low precursor frequencies<br />
Sab<strong>in</strong>e Tischer, Hannover<br />
P7.02 Insect <strong>Cell</strong>s to Analyze the Individual Interaction Between the Human<br />
Activat<strong>in</strong>g Natural Killer <strong>Cell</strong> Receptor NKp30 <strong>and</strong> its Lig<strong>and</strong> B7H6<br />
Julia Herrmann, Frankfurt<br />
P7.03 Retargeted Natural Killer <strong>Cell</strong>s for Adoptive Cancer Immunotherapy<br />
W<strong>in</strong>fried Wels, Frankfurt<br />
P7.04 Immune regeneration under immune suppression: lentivirus-<strong>in</strong>duced<br />
dendritic cells co-express<strong>in</strong>g pp65, GM-CSF <strong>and</strong> IFN-a for precondition<strong>in</strong>g<br />
the recipient prior to donor lymphocyte <strong>in</strong>fusions<br />
Renata Stripecke, Hannover<br />
P7.05 Immune Suppression by Mesenchymal Stromal <strong>Cell</strong>s (MSCs) is<br />
Mediated via Galect<strong>in</strong>-9<br />
Christopher Ungerer, Frankfurt<br />
P7.06 <strong>Gene</strong>ration of retroviral vectors encod<strong>in</strong>g WT1-specific TCRs for the<br />
transduction of mature T cells<br />
Mart<strong>in</strong>a Anzaghe, Frankfurt<br />
36
Change language